Korro Bio, Inc.
KRRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703647
In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 7 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Korro Bio, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 84 | 1 | 75 | −8 |
| Shares | 9.45M | 28.3K | 9.70M | +286.2K (+3.0%) |
| Value | $359.6M | $1.08M | $169.0M | −$189.6M (−52.9%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Korro Bio, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cormorant Asset Management, LP | 380,303 | $6.62M | 0.50% |
| Standard Life Aberdeen plc | 84,428 | $1.47M | 0.00% |
| DAFNA Capital Management LLC | 47,086 | $819.8K | 0.23% |
| Nuveen, LLC | 12,145 | $211.4K | 0.00% |
| XTX Topco Ltd | 10,600 | $184.5K | 0.01% |
| Susquehanna International Group, LLP | 10,372 | $180.6K | 0.00% |
| Quarry LP | 2,011 | $35.0K | 0.01% |
| Federated Hermes, Inc. | 64 | $1.11K | 0.00% |
| BNP Paribas | 59 | $1.03K | 0.00% |
| True Wealth Design, LLC | 1 | $18 | 0.00% |
Sold out (18)
Institutions that held Korro Bio, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Eventide Asset Management, LLC | 117,556 | $4.48M |
| Verition Fund Management LLC | 62,094 | $2.36M |
| Marshall Wace, LLP | 18,461 | $702.8K |
| Wellington Management Group LLP | 14,553 | $554.0K |
| Swiss National Bank | 10,000 | $380.7K |
| Jane Street Group, LLC | 7,604 | $289.5K |
| Balyasny Asset Management LLC | 5,778 | $220.0K |
| Bank of Montreal | 5,710 | $217.4K |
| HRT Financial LP | 5,703 | $217.0K |
| Trexquant Investment LP | 5,539 | $210.9K |
| KLP Kapitalforvaltning AS | 1,400 | $53.3K |
| Meeder Asset Management Inc | 357 | $13.6K |
| US Bancorp | 87 | $3.31K |
| Signaturefd, LLC | 41 | $1.56K |
| Caitong International Asset Management Co., Ltd | 41 | $1.56K |
| Lindbrook Capital, LLC | 31 | $1.18K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 20 | $761 |
| Allworth Financial LP | 3 | $115 |
Not filed for Q1 2025 yet (1)
Institutions that held Korro Bio, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 28,295 | $1.08M |